RECEIVE REPORT STATUS AND QUICK ACCESS TO PATIENT INFORMATION /// EXPLORE NOW

img

Precision Medicine Company utilizing Advanced Molecular Diagnostics merged with Machine Learning.

Artificial Intelligence-powered treatment algorithms bringing specialist-level care and advanced capabilities to local community-based healthcare.

LEARN MORE

Precision Medicine Company utilizing Advanced Molecular Diagnostics merged with Machine Learning.

Artificial Intelligence-powered treatment algorithms bringing specialist-level care and advanced capabilities to local community-based healthcare.

LEARN MORE

Sign up to Receive updates

Ai enabled Precision medicine

AI-enabled Precision medicine

Bringing the power of data and artificial intelligence to healthcare

blue x-ray

Pathogen Testing Services

SIGNAL DIAGNOSTICS advanced molecular pathogen detection system identifies a vast majority of known human pathogens, including those in urinary tract infections, gynecologic infections, sexually transmitted diseases, gastrointestinal infections, wound infections, and nail infections, as well as respiratory diseases. Our Pathogen Diagnosis, Molecular Diagnostics, Precision Medicine Diagnostics, and Infectious Disease Testing offer 100% reliable and accurate results.

WHAT WE ALSO DO

AI-driven Healthcare

CLINICAL DECISION SUPPORT

Signal Diagnostics has laboratory physicians able to assist in test interpretation and provide guidance on utilization, treatment plans and recommendations on additional studies if needed.

LEARN MORE
Advanced Diagnostic Technology

ADVANCED DIGITAL PATHOLOGY SERVICES

Signal Diagnostics is also a leader in digital pathology and we are currently expanding our team’s expertise in both computational image analysis as well as traditional telepathology services to support our clinicians.

LEARN MORE
Lab Services

LAB CONSULTATION SERVICES

In addition to our in house lab services, we also provide consultation services for laboratories looking to add these advanced capabilities to their facilities.

LEARN MORE
Lab Services

NOVEL COVERED BLADDER CANCER SCREENING ASSAY

In the wake of Medicare’s recent decision to discontinue coverage for Abbott’s Urovysion FISH testing, Signal Diagnostics has partnered with KDX Diagnostics to provide a novel proprietary urine screening assay using Medicare covered immunohistochemistry codes that provides a more sensitive and specific test for bladder cancer screening.

LEARN MORE
Quality Inspection Lab

WHY CHOOSE US

SIGNAL DIAGNOSTICS offers convenient, local 24-hour turnaround time with high-quality customer service that includes on-call after-hours support from our expert physician staff that separates our lab services from large commercial labs. We also have the most superior Advanced Diagnostic Technology in our Colorado Testing Laboratory! At Signal Diagnostics, we take pride in providing the best medical and diagnostics services and medical lab services to our patients.

News & Articles

best medical and diagnostics
APRIL 2023

THE MOLECULAR ADVANTAGE

Urinary tract infections (UTIs) are among the most common infections in humans, with and estimated seven million patient visits and a cost of $1.6 billion USD per year.

By Dr. Brian Kelly, J Mass Spectrom Adv Clin Lab. 2023 Apr; 28: 60–62. READ MORE ➞
Artificial Intelligence in Healthcare
DECEMBER 2022

CHALLENGING THE UTI TESTING GOLD STANDARD

Though women and older adults are most vulnerable, many people will experience a urinary tract infection (UTI) during their lifetimes. These common infections of the urinary system impact the kidneys, bladder, or urethra. In the United States alone, UTIs account for more than 8 million doctor visits each year . Though not typically life threatening, UTIs can cause serious complications if left untreated and UTI-related hospitalizations cost an estimated $2.8 billion annually in the United States .

By Thermofisher Scientific, Dec 15, 2022 READ MORE ➞
Pathology and Laboratory Services
MARCH 2023

UROLOGY TIMES: THE STATUS AND FUTURE DIRECTION OF ADVANCED URINE TESTING: MULTIPLEX PCR

More than half of adult women in the United States will have at least ? urinary tract infection (UTI) with an estimated annual cost burden of $1.6 billion. Among these women, 25% to 50% will develop recurrent UTI (rUTI), which is defined as at least 2 infections in a 6-month period or at least 3 in 1 year. The gold standard for UTI diagnosis is urinalysis and standard urine culture (SUC), where a positive result is defined as 105 colony forming units (CFU). Yet SUC has many shortcomings, including a false negative rate of 20% to 30% among symptomatic subjects.

By Stephanie Gleicher, MD, MPH and Roger Dmochowski, MD, FACS READ MORE ➞

SIGNAL DIAGNOSTICS

is CLIA certified

Colorado Lab